A. Mutsaers, W. Widmer, and D. Knapp, Canine Transitional Cell Carcinoma, Journal of Veterinary Internal Medicine, vol.66, issue.2, pp.136-144, 2003.
DOI : 10.1093/gerona/52A.3.B171

D. Knapp, J. Ramos-vara, G. Moore, D. Dhawan, P. Bonney et al., Urinary Bladder Cancer in Dogs, a Naturally Occurring Model for Cancer Biology and Drug Development, ILAR Journal, vol.5, issue.3, pp.100-118, 2014.
DOI : 10.1517/17425247.5.3.309
URL : https://academic.oup.com/ilarjournal/article-pdf/55/1/100/7554885/ilu018.pdf

M. Raghavan, D. Knapp, P. Bonney, M. Dawson, and L. Glickman, Evaluation of the effect of dietary vegetable consumption on reducing risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers, Journal of the American Veterinary Medical Association, vol.227, issue.1, pp.94-100, 2005.
DOI : 10.2460/javma.2005.227.94

M. Raghavan, D. Knapp, M. Dawson, P. Bonney, and L. Glickman, Topical flea and tick pesticides and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers, Journal of the American Veterinary Medical Association, vol.225, issue.3, pp.389-394, 2004.
DOI : 10.2460/javma.2004.225.389

L. Glickman, M. Raghavan, D. Knapp, P. Bonney, and M. Dawson, Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers, Journal of the American Veterinary Medical Association, vol.224, issue.8, pp.1290-1297, 2004.
DOI : 10.2460/javma.2004.224.1290

S. Withrow, D. Vail, and R. Page, Small Animal Clinical Oncology, Tumors of the urinary System, 2013.

D. Knapp, N. Glickman, D. Denicola, P. Bonney, T. Lin et al., Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer, Urologic Oncology: Seminars and Original Investigations, vol.5, issue.2, pp.47-59, 2000.
DOI : 10.1016/S1078-1439(99)00006-X

V. Valli, A. Norris, R. Jacobs, E. Laing, S. Withrow et al., Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival, Journal of Comparative Pathology, vol.113, issue.2, pp.113-130, 1995.
DOI : 10.1016/S0021-9975(05)80027-1

L. N. , TNM Classifi cation of Tumors in Domestic Animals, Geneva: World Health Organization, 1980.

C. Fulkerson and D. Knapp, Management of transitional cell carcinoma of the urinary bladder in dogs: A review, The Veterinary Journal, vol.205, issue.2, pp.217-225, 2015.
DOI : 10.1016/j.tvjl.2015.01.017

D. Knapp, C. Henry, W. Widmer, K. Tan, G. Moore et al., Randomized Trial of Cisplatin versus Firocoxib versus Cisplatin/Firocoxib in Dogs with Transitional Cell Carcinoma of the Urinary Bladder, Journal of Veterinary Internal Medicine, vol.5, issue.1, pp.126-133, 2013.
DOI : 10.1016/S1078-1439(99)00006-X

C. Cannon and S. Allstadt, Lower Urinary Tract Cancer, Veterinary Clinics of North America: Small Animal Practice, vol.45, issue.4, pp.807-824, 2015.
DOI : 10.1016/j.cvsm.2015.02.008

A. Morales and Z. Cohen, cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin, Expert Opinion on Biological Therapy, vol.111, issue.2, pp.273-283, 2016.
DOI : 10.1093/jnci/djq495

A. Morales, K. Phadke, and G. Steinhoff, Intravesical Mycobacterial Cell Wall-DNA Complex in the Treatment of Carcinoma In Situ of the Bladder After Standard Intravesical Therapy Has Failed, The Journal of Urology, vol.181, issue.3, pp.1040-1045, 2009.
DOI : 10.1016/j.juro.2008.11.019

A. Morales, Evolution of intravesical immunotherapy for bladder cancer: mycobacterial cell wall preparation as a promising agent, Expert Opinion on Investigational Drugs, vol.91, issue.7, pp.1067-1073, 2008.
DOI : 10.1016/j.urolonc.2007.04.005

A. Morales, J. Chin, and E. Ramsey, MYCOBACTERIAL CELL WALL EXTRACT FOR TREATMENT OF CARCINOMA IN SITU OF THE BLADDER, The Journal of Urology, vol.166, issue.5, pp.1633-1637, 2001.
DOI : 10.1016/S0022-5347(05)65642-X

J. Chin, S. Kadhim, E. Batislam, S. Karlik, B. Garcia et al., Mycobacterium Cell Wall, The Journal of Urology, vol.156, pp.1189-1193, 1996.
DOI : 10.1097/00005392-199609000-00107

. Alkemade, . Sj, T. Buckley, and M. G. , Immunostimulatory bacterial cell wall fraction, 1998.

M. Filion and N. Phillips, Therapeutic potential of mycobacterial cell wall-DNA complexes, Expert Opin Investig Drugs, vol.10, pp.2157-2165, 2001.

L. Rodrigues and A. Masic, Mycobacterium Cell Wall Fraction (Immunocidin®) for Canine Transitional Cell Carcinoma Treatment. Veterinary Cancer Society Conference 2015, p.29

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983.
DOI : 10.1016/0022-1759(83)90303-4

, Veterinary cooperative oncology group -common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1, Vet Comp Oncol, vol.1, 2011.

S. Mcmillan, P. Boria, G. Moore, W. Widmer, P. Bonney et al., Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder, Journal of the American Veterinary Medical Association, vol.239, issue.8, pp.1084-1089, 2011.
DOI : 10.2460/javma.239.8.1084

S. Lynch, K. Savary-bataille, B. Leeuw, and D. Argyle, Development of a questionnaire assessing health-related quality-of-life in dogs and cats with cancer, Veterinary and Comparative Oncology, vol.226, issue.3, pp.172-182, 2011.
DOI : 10.2460/javma.2005.226.722

J. Naughton, W. Widmer, P. Constable, and D. Knapp, Accuracy of three-dimensional and two-dimensional ultrasonography for measurement of tumor volume in dogs with transitional cell carcinoma of the urinary bladder, American Journal of Veterinary Research, vol.73, issue.12, pp.1919-1924, 2012.
DOI : 10.2460/ajvr.73.12.1919

S. Nguyen, D. Thamm, D. Vail, and C. London, Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document, Veterinary and Comparative Oncology, vol.13, issue.3, 2013.
DOI : 10.1111/vco.12032

D. W. Knapp, B. , M. C. Filion, and N. C. Phillips, Antitumor activity of mycobacterial cell wall-DNA complex (MCC) against canine urinary bladder transitional cell carcinoma cells. Veterinary Cancer Society Annual Conference Kansas City, Kansas City Missouri, pp.46-47, 2004.

I. Azuma, T. Taniyama, F. Hirao, and Y. Yamamura, Antitumor activity of cell-wall skeletons and peptidoglycolipids of mycobacteria and related microorganisms in mice and rabbits, Gan, vol.65, pp.493-505, 1974.

M. Filion, P. Lepicier, A. Morales, and N. Phillips, Mycobacterium phlei cell wall complex directly induces apoptosis in human bladder cancer cells, British Journal of Cancer, vol.7, issue.1, pp.229-235, 1999.
DOI : 10.1038/bjc.1995.155

E. Fumuso, J. Aguilar, S. Giguere, M. Rivulgo, J. Wade et al., Immune parameters in mares resistant and susceptible to persistent post-breeding endometritis: Effects of immunomodulation, Veterinary Immunology and Immunopathology, vol.118, issue.1-2, pp.30-39, 2007.
DOI : 10.1016/j.vetimm.2007.04.009

S. Reader, S. Menard, B. Filion, M. Filion, and N. Phillips, Pro-apoptotic and immunomodulatory activity of a mycobacterial cell wall-DNA complex towards LNCaP prostate cancer cells, The Prostate, vol.10, issue.Suppl 3, pp.155-165, 2001.
DOI : 10.1016/S0962-8924(00)01803-1

K. Yamanaka, I. Hara, H. Nagai, H. Miyake, K. Gohji et al., Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model, Cancer Immunology, Immunotherapy, vol.48, issue.6, pp.297-302, 1999.
DOI : 10.1007/s002620050578

M. Filion, B. Filion, S. Reader, S. Menard, and N. Phillips, Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex, Cancer Immunology, Immunotherapy, vol.49, issue.6, pp.325-334, 2000.
DOI : 10.1007/s002620000121

D. Knapp, R. Richardson, T. Chan, G. Bottoms, W. Widmer et al., Piroxicam Therapy in 34 Dogs With Transitional Cell Carcinoma of the Urinary Bladder, Journal of Veterinary Internal Medicine, vol.31, issue.4, pp.273-278, 1994.
DOI : 10.1038/bjc.1983.251